FDA approves selinexor for relapsed/refractory diffuse large B-cell lymphoma
The Food and Drug Administration (FDA) granted accelerated approval to selinexor for adult patients with…
Browsing: selinexor
Drugs reprogram genes in breast tumours to prevent endocrine resistance
Treating breast tumours with two cancer drugs simultaneously may prevent endocrine resistance by attacking the…